BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29045674)

  • 1. RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
    Page BJ; Bowman RV; Yang IA; Fong KM
    J Natl Cancer Inst; 2018 Apr; 110(4):432. PubMed ID: 29045674
    [No Abstract]   [Full Text] [Related]  

  • 2. Never smokers with lung cancer: analysis of genetic variants.
    Xiao H; Ding J; Gao S; Yang S; Huang Y
    Asian Pac J Cancer Prev; 2011; 12(10):2807-9. PubMed ID: 22320997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Italian Nivolumab Expanded Access Program Confirms the Limitations of Single-Agent PD-1 Inhibition in EGFR-Mutant and Never-Smoking Patients with NSCLC.
    Lisberg A; Garon EB
    J Thorac Oncol; 2018 Aug; 13(8):1058-1059. PubMed ID: 30056858
    [No Abstract]   [Full Text] [Related]  

  • 4. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
    J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportion and clinical features of never-smokers with non-small cell lung cancer.
    Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
    Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer.
    Hanagiri T; Sugio K; Mizukami M; Ichiki Y; Sugaya M; Yasuda M; Takenoyama M; Yasumoto K
    J Thorac Oncol; 2008 Oct; 3(10):1127-32. PubMed ID: 18827608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple primary malignancies in patients with non-small cell lung cancer.
    Fujita S; Masago K; Takeshita J; Togashi Y; Hata A; Kaji R; Kokubo M; Katakami N
    Intern Med; 2015; 54(3):325-31. PubMed ID: 25748742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
    Muallaoglu S; Karadeniz C; Mertsoylu H; Ayberk Besen A; Sezer A; Murat Sedef A; Kose F; Ozyilkan O
    J BUON; 2014; 19(2):453-8. PubMed ID: 24965406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature.
    Hasegawa Y; Ando M; Kubo A; Isa S; Yamamoto S; Tsujino K; Kurata T; Ou SH; Takada M; Kawaguchi T
    Lung Cancer; 2014 Jan; 83(1):8-13. PubMed ID: 24252423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
    Ferketich AK; Niland JC; Mamet R; Zornosa C; D'Amico TA; Ettinger DS; Kalemkerian GP; Pisters KM; Reid ME; Otterson GA
    Cancer; 2013 Feb; 119(4):847-53. PubMed ID: 23023590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.
    Bhatt VR; Batra R; Silberstein PT; Loberiza FR; Ganti AK
    Med Oncol; 2015 Jan; 32(1):339. PubMed ID: 25429831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
    Garassino MC; Crinò L; Catino A; Ardizzoni A; Cortesi E; Cappuzzo F; Bordi P; Calabrò L; Barbieri F; Santo A; Altavilla G; Ambrosio F; Mini E; Vasile E; Morgillo F; Scoppola A; Bengala C; Follador A; Tedde N; Giannarelli D; Lo Russo G; Vitiello F
    Tumour Biol; 2018 Nov; 40(11):1010428318815047. PubMed ID: 30486741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
    Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
    Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.
    Boyle JM; Tandberg DJ; Chino JP; D'Amico TA; Ready NE; Kelsey CR
    Cancer; 2015 Feb; 121(4):598-604. PubMed ID: 25283893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer in never-smokers - what are the differences?
    Dias M; Linhas R; Campainha S; Conde S; Barroso A
    Acta Oncol; 2017 Jul; 56(7):931-935. PubMed ID: 28514931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients.
    Couto PP; Bastos-Rodrigues L; Schayek H; Melo FM; Lisboa RGC; Miranda DM; Vilhena A; Bale AE; Friedman E; De Marco L
    Carcinogenesis; 2017 Oct; 38(11):1112-1118. PubMed ID: 28968711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
    Subramanian J; Velcheti V; Gao F; Govindan R
    J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.
    Szymanowska-Narloch A; Jassem E; Skrzypski M; Muley T; Meister M; Dienemann H; Taron M; Rosell R; Rzepko R; Jarząb M; Marjański T; Pawłowski R; Rzyman W; Jassem J
    Adv Med Sci; 2013; 58(2):196-206. PubMed ID: 24451080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the Japan molecular epidemiology for lung cancer study.
    Kawaguchi T; Ando M; Ito N; Isa S; Tamiya A; Shimizu S; Saka H; Kubo A; Koh Y; Matsumura A
    Clin Lung Cancer; 2013 Sep; 14(5):596-600. PubMed ID: 23685138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.